BACK

0.00030.00%
PB

Peter Beitsch

Independent Director

Dr. Peter Beitsch, M.D., serves as an Independent Director at IMAC Holdings, Inc. since June 26, 2024. He serves as Advisor at Health Innovation Pitch. He is Director of Juva Life Inc. from August 1, 2021. has been in private medical practice with a focus on melanoma and breast cancer. He has held numerous positions in national surgical societies including the American Society of Breast Surgeons where he served as President of the Society from 2013-14, Program Director for the 2005 Annual Meeting in Los Angeles, Board of Directors Member from 2006-9 and 2012-15. He was a National Ultrasound Faculty for the American College of Surgeons. He has presented internationally and is actively involved in breast cancer and melanoma research. He has authored major articles in peer-reviewed medical journals including the New England Journal of Medicine, the Journal of the American Medical Association, the Proceedings of the National Academy of Science, Journal of Clinical Oncology and the Annals of Surgical Oncology. He was a co-founder of and remains involved with, Targeted Medical Education, which has been involved in studies and clinical trials for breast cancer research and which was acquired by Aptitude Health in 2022. He trained in general surgery residency at Parkland Hospital in Dallas from 1986 to 1993, during which he received a 2 year National Cancer Institute fellowship at M.D. Anderson Cancer Center from 1988-90. He completed his training with a surgical oncology fellowship at the John Wayne Cancer Institute in Santa Monica, California. He attended the University of Texas Southwestern Medical School in Dallas.

Positions